Hodgkin disease and red cell aplasia

Elaine R Morgan*, Kin Man Pang, E. Goldwasser

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


A teenage boy with mixed‐cellularity Hodgkin disease presented with severe anemia secondary to pure red cell aplasia of marrow without evidence of lymphomatous infiltration or hemolysis. In vitro studies of the patient's serum demonstrated an inhibitor of erythropoietin activity which appeared to be an IgG but which did not directly bind erythropoietin. The patient's anemia resolved and the inhibitor disappeared following chemotherapy for Hodgkin disease. Presumably, the inhibitor was directed at a very early stage of red blood cell production. This phenomenon may be related to other autoimmune manifestations occasionally seen in patients with lymphomas. The case is presented to bring attention to the unusual occurrence of red cell aplasia in Hodgkin disease. Several hypotheses concerning significance and etiology of the anemia are detailed.

Original languageEnglish (US)
Pages (from-to)71-75
Number of pages5
JournalAmerican Journal of Hematology
Issue number1
StatePublished - 1978


  • Hodgkin disease
  • anemia erythropoietin inhibitor
  • red cell aplasia

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Hodgkin disease and red cell aplasia'. Together they form a unique fingerprint.

Cite this